Exclusive Networks Leads 3 High Growth Stocks With Insider Ownership On Euronext Paris

As the French stock market navigates the challenges of geopolitical tensions and economic fluctuations, highlighted by a recent decline in major indices like the CAC 40, investors are increasingly seeking stability and potential growth in companies with strong insider ownership. In this context, stocks that exhibit high insider ownership can offer an added layer of confidence to investors, as they often indicate management's commitment to long-term success and alignment with shareholder interests.

Top 10 Growth Companies With High Insider Ownership In France

Name	Insider Ownership	Earnings Growth
Groupe OKwind Société anonyme (ENXTPA:ALOKW)	20.6%	36%
STIF Société anonyme (ENXTPA:ALSTI)	16.4%	35.1%
VusionGroup (ENXTPA:VU)	13.4%	81.7%
Icape Holding (ENXTPA:ALICA)	30.2%	33.9%
Arcure (ENXTPA:ALCUR)	21.4%	26.6%
La Française de l'Energie (ENXTPA:FDE)	19.9%	31.9%
S.M.A.I.O (ENXTPA:ALSMA)	17.4%	35.2%
Adocia (ENXTPA:ADOC)	11.7%	64%
Munic (ENXTPA:ALMUN)	27.1%	174.1%
MedinCell (ENXTPA:MEDCL)	15.8%	93.9%

Click here to see the full list of 21 stocks from our Fast Growing Euronext Paris Companies With High Insider Ownership screener.

Let's uncover some gems from our specialized screener.

Exclusive Networks (ENXTPA:EXN)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Exclusive Networks SA is a global cybersecurity specialist focusing on digital infrastructure, with a market cap of €2.14 billion.

Operations: Exclusive Networks generates revenue from three main regions: €480 million from APAC, €4.19 billion from EMEA, and €705 million from the Americas.

Insider Ownership: 13.1%

Exclusive Networks, a French cybersecurity firm, is poised for significant earnings growth at 33.5% annually over the next three years, surpassing the French market's 12.1%. Despite lower profit margins compared to last year, insider ownership remains high with Permira and founder Olivier Breittmayer holding 66.7%. A proposed buyout by Clayton, Dubilier & Rice and Permira values the company at €2.2 billion (US$2.4 billion), offering a premium of €24.25 per share to shareholders pending regulatory approval.

• Get an in-depth perspective on Exclusive Networks' performance by reading our analyst estimates report here.
• Upon reviewing our latest valuation report, Exclusive Networks' share price might be too optimistic.

Lectra (ENXTPA:LSS)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Lectra SA offers industrial intelligence solutions to the fashion, automotive, and furniture industries across Northern Europe, Southern Europe, the Americas, and the Asia Pacific with a market cap of €1.08 billion.

Operations: The company's revenue segments include €172.65 million from the Americas and €118.54 million from the Asia-Pacific region.

Insider Ownership: 19.6%

Lectra, a French technology firm, is expected to see its earnings grow significantly at 29.3% annually over the next three years, outpacing the French market's growth. Despite a recent drop from the S&P Global BMI Index and declining net income in its latest half-year report (€12.51 million), Lectra's revenue is forecast to increase by 10.4% annually. Analysts agree on a potential stock price rise of 21.3%, with shares trading below estimated fair value by 46.4%.

• Unlock comprehensive insights into our analysis of Lectra stock in this growth report.
• The valuation report we've compiled suggests that Lectra's current price could be quite moderate.

MedinCell (ENXTPA:MEDCL)

Simply Wall St Growth Rating: ★★★★★☆

Overview: MedinCell S.A. is a pharmaceutical company based in France that specializes in developing long-acting injectables across various therapeutic areas, with a market cap of €436.31 million.

Operations: MedinCell S.A. generates its revenue primarily from its pharmaceuticals segment, amounting to €11.95 million.

Insider Ownership: 15.8%

MedinCell's growth prospects are promising, with expected annual revenue growth of 46.2%, significantly outpacing the French market. The company is forecast to become profitable within three years and trades at a substantial discount to estimated fair value. Recent strategic collaborations, such as with AbbVie, enhance its innovative pipeline and potential revenue streams. Governance changes include a new Board structure and CEO appointment, potentially aligning leadership with its ambitious growth trajectory.

• Take a closer look at MedinCell's potential here in our earnings growth report.
• Our expertly prepared valuation report MedinCell implies its share price may be lower than expected.

Taking Advantage

• Embark on your investment journey to our 21 Fast Growing Euronext Paris Companies With High Insider Ownership selection here.
• Have you diversified into these companies? Leverage the power of Simply Wall St's portfolio to keep a close eye on market movements affecting your investments.
• Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.

Want To Explore Some Alternatives?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com